Does ANIDULAFUNGIN Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with ANIDULAFUNGIN (ERAXIS). This represents 0.9% of all adverse event reports for ANIDULAFUNGIN.
6
Reports of Interstitial lung disease with ANIDULAFUNGIN
0.9%
of all ANIDULAFUNGIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Interstitial lung disease From ANIDULAFUNGIN?
Of the 6 reports.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANIDULAFUNGIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ANIDULAFUNGIN Cause?
Drug ineffective (234)
Multiple organ dysfunction syndrome (108)
Off label use (85)
Candida infection (61)
Death (57)
Neutropenia (53)
Pneumonia (49)
Septic shock (45)
Sepsis (42)
Condition aggravated (37)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ANIDULAFUNGIN Alternatives Have Lower Interstitial lung disease Risk?
ANIDULAFUNGIN vs ANIFROLUMAB
ANIDULAFUNGIN vs ANIFROLUMAB-FNIA
ANIDULAFUNGIN vs ANTHOXANTHUM ODORATUM POLLEN\DACTYLIS GLOMERATA POLLEN\LOLIUM PERENNE POLLEN\PHLEUM PRATENSE POLLEN\POA PRATENSIS POLLEN
ANIDULAFUNGIN vs ANTI-INHIBITOR COAGULANT COMPLEX
ANIDULAFUNGIN vs ANTIHEMOPHILIC FACTOR HUMAN